Loading stock analysis…
Evidence Synthesis
Last synthesized: 10 Jul 2026, 09:49
Narrative updating · score is newerEvidence Synthesis
JUBLPHARMA closed at INR 970.75 on July 8, 2026, with a daily volume of 62386 shares.
The company's gross margin accelerated to , up from 9.72%. Revenue growth year-over-year accelerated to , up from -22.4%. Marginal operating leverage accelerated to , up from 4.81%.
Source observations behind the synthesis narrative.
| Metric | Value | Previous Value | Trend |
|---|---|---|---|
| GROSS_MARGIN | 68.06 % | 9.72 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 9.72 % | 4.81 | ▲ |
| REVENUE_GROWTH_YOY | 18.7 % | -22.4 | ▲ |
| EPS_ACTUAL | 7.845 INR | 5.014 | ▲ |
| EPS_SURPRISE_PERCENT | 0.105 % | -0.273 | ▲ |
| PRICE_CHANGE_PERCENT | -0.822 % | — | - |
| DAILY_VOLUME | 62,386 shares | 1,16,103 | ▼ |
| CLOSE_PRICE | 970.75 INR | 978.8 | ▼ |
| NEWS_SENTIMENT_SCORE | 0 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 0 count | 1 | ▼ |
| TARGET_PRICE_PREMIUM | 17.33 % | — | - |